Gemini Therapeutics, Inc.
GMTX
NASDAQ Global Market1.35
USD
- -
- -
Total Valuation
Gemini Therapeutics, Inc. carries a market capitalization of 25.49M, placing it among publicly traded companies globally.
| Market Cap | 25.49M |
| Enterprise Value | N/A |
Stock Price Statistics
Gemini Therapeutics, Inc.'s stock has declined approximately -91.81818% over the past 52 weeks. The 50-day moving average sits at 16.65, while the 200-day moving average is 15.80.
| Beta (5Y) | N/A |
| 52-Week Price Change | -91.81818% |
| 50-Day Moving Average | 16.65 |
| 200-Day Moving Average | 15.80 |
| Average Volume (20 Days) | N/A |
Stock Splits
Gemini Therapeutics, Inc.'s most recent stock split took place on December 30, 2022 with a 10:1 split ratio.
| Last Split Date | 12/30/2022 |
| Split Ratio | 10:1 |